JPH0566141B2 - - Google Patents
Info
- Publication number
- JPH0566141B2 JPH0566141B2 JP3150277A JP15027791A JPH0566141B2 JP H0566141 B2 JPH0566141 B2 JP H0566141B2 JP 3150277 A JP3150277 A JP 3150277A JP 15027791 A JP15027791 A JP 15027791A JP H0566141 B2 JPH0566141 B2 JP H0566141B2
- Authority
- JP
- Japan
- Prior art keywords
- capsule
- cap
- container
- vial
- view
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002775 capsule Substances 0.000 claims description 66
- 239000003814 drug Substances 0.000 claims description 36
- 229940079593 drug Drugs 0.000 claims description 34
- 238000001802 infusion Methods 0.000 claims description 29
- 239000007788 liquid Substances 0.000 claims description 25
- 238000004891 communication Methods 0.000 claims description 20
- 239000012528 membrane Substances 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 10
- 238000007865 diluting Methods 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 29
- 230000008878 coupling Effects 0.000 description 14
- 238000010168 coupling process Methods 0.000 description 14
- 238000005859 coupling reaction Methods 0.000 description 14
- 238000003825 pressing Methods 0.000 description 11
- 239000000126 substance Substances 0.000 description 10
- 210000000078 claw Anatomy 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229920005672 polyolefin resin Polymers 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- REACMANCWHKJSM-DWBVFMGKSA-M Cefsulodin sodium Chemical compound [Na+].C1=CC(C(=O)N)=CC=[N+]1CC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)[C@@H](C=3C=CC=CC=3)S([O-])(=O)=O)[C@H]2SC1 REACMANCWHKJSM-DWBVFMGKSA-M 0.000 description 1
- URDOHUPGIOGTKV-JTBFTWTJSA-M Cefuroxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 URDOHUPGIOGTKV-JTBFTWTJSA-M 0.000 description 1
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 1
- 229960001931 ampicillin sodium Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- CZTQZXZIADLWOZ-CRAIPNDOSA-N cefaloridine Chemical compound O=C([C@@H](NC(=O)CC=1SC=CC=1)[C@H]1SC2)N1C(C(=O)[O-])=C2C[N+]1=CC=CC=C1 CZTQZXZIADLWOZ-CRAIPNDOSA-N 0.000 description 1
- 229960003866 cefaloridine Drugs 0.000 description 1
- OJMNTWPPFNMOCJ-CFOLLTDRSA-M cefamandole sodium Chemical compound [Na+].CN1N=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)[C@H](O)C=3C=CC=CC=3)[C@H]2SC1 OJMNTWPPFNMOCJ-CFOLLTDRSA-M 0.000 description 1
- 229960003408 cefazolin sodium Drugs 0.000 description 1
- FLKYBGKDCCEQQM-WYUVZMMLSA-M cefazolin sodium Chemical compound [Na+].S1C(C)=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 FLKYBGKDCCEQQM-WYUVZMMLSA-M 0.000 description 1
- 229960003791 cefmenoxime Drugs 0.000 description 1
- MPTNDTIREFCQLK-UNVJPQNDSA-N cefmenoxime hydrochloride Chemical compound [H+].[Cl-].S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NN=NN1C.S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NN=NN1C MPTNDTIREFCQLK-UNVJPQNDSA-N 0.000 description 1
- SNBUBQHDYVFSQF-HIFRSBDPSA-N cefmetazole Chemical compound S([C@@H]1[C@@](C(N1C=1C(O)=O)=O)(NC(=O)CSCC#N)OC)CC=1CSC1=NN=NN1C SNBUBQHDYVFSQF-HIFRSBDPSA-N 0.000 description 1
- 229960002676 cefmetazole sodium Drugs 0.000 description 1
- 229960004682 cefoperazone Drugs 0.000 description 1
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 description 1
- ZQQALMSFFARWPK-ZTQQJVKJSA-L cefotetan disodium Chemical compound [Na+].[Na+].N([C@]1(OC)C(N2C(=C(CSC=3N(N=NN=3)C)CS[C@@H]21)C([O-])=O)=O)C(=O)C1SC(=C(C(N)=O)C([O-])=O)S1 ZQQALMSFFARWPK-ZTQQJVKJSA-L 0.000 description 1
- BWRRTAXZCKVRON-DGPOFWGLSA-N cefotiam dihydrochloride Chemical compound Cl.Cl.CN(C)CCN1N=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CC=3N=C(N)SC=3)[C@H]2SC1 BWRRTAXZCKVRON-DGPOFWGLSA-N 0.000 description 1
- 229960004700 cefotiam hydrochloride Drugs 0.000 description 1
- 229960005446 cefpiramide Drugs 0.000 description 1
- PWAUCHMQEXVFJR-PMAPCBKXSA-N cefpiramide Chemical compound C1=NC(C)=CC(O)=C1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 PWAUCHMQEXVFJR-PMAPCBKXSA-N 0.000 description 1
- 229960004366 ceftezole Drugs 0.000 description 1
- DZMVCVMFETWNIU-LDYMZIIASA-N ceftezole Chemical compound O=C([C@@H](NC(=O)CN1N=NN=C1)[C@H]1SC2)N1C(C(=O)O)=C2CSC1=NN=CS1 DZMVCVMFETWNIU-LDYMZIIASA-N 0.000 description 1
- 229960000636 ceftizoxime sodium Drugs 0.000 description 1
- ADLFUPFRVXCDMO-LIGXYSTNSA-M ceftizoxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=CCS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 ADLFUPFRVXCDMO-LIGXYSTNSA-M 0.000 description 1
- 229960000534 cefuroxime sodium Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 229960000684 cytarabine Drugs 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- FWRNIJIOFYDBES-ZQDFAFASSA-L disodium;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[[(2r)-2-phenyl-2-sulfonatoacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Chemical compound [Na+].[Na+].C1([C@H](C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)S([O-])(=O)=O)=CC=CC=C1 FWRNIJIOFYDBES-ZQDFAFASSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229960001520 ranitidine hydrochloride Drugs 0.000 description 1
- GGWBHVILAJZWKJ-KJEVSKRMSA-N ranitidine hydrochloride Chemical compound [H+].[Cl-].[O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 GGWBHVILAJZWKJ-KJEVSKRMSA-N 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- WFWLQNSHRPWKFK-ZCFIWIBFSA-N tegafur Chemical compound O=C1NC(=O)C(F)=CN1[C@@H]1OCCC1 WFWLQNSHRPWKFK-ZCFIWIBFSA-N 0.000 description 1
- 229960001674 tegafur Drugs 0.000 description 1
- 229960004659 ticarcillin Drugs 0.000 description 1
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Description
ããã茞液容åšã«é¢ãããã®ã§ãããå»çã®åé
ã§çšããããã
ããŠã¯ããã€ã¢ã«çã®å®¹åšã«å ¥ã€ãç²æ«è¬å€ãã
ãã¯åçµä¹Ÿç¥è¬å€ã溶解ããŠèŒžæ¶²ãšããŠç¹æ»Žæ³šå°
ã«çšãããããã®éã«ãäžèšè¬å€ã®å ¥ã€ã容åšãš
ãã®è¬å€ã®æº¶è§£æ¶²ã®å ¥ã€ã容åšãšãäž¡é éããã
ã¯é£çµç®¡çã®æ¥ç¶çšå ·ãçšããŠæ¥ç¶ãã溶解液ã
è¬å€ã®å ¥ã€ã容åšã«ç§»ããè¬å€ã溶解ããŠããã
ãäžã«ãå€æ°äžã§è¬å€ã®å ¥ã€ã容åšã«æ¥ç¶çšã®ç©Ž
ããããæäœãè¡ãªãã®ã§ãäžã®è¬å€ãæ±æãã
ãå¯èœæ§ãããã
ã®ãšããŠãç¹è¡šæ61â501129å·å ¬å ±ã«ç€ºãããã
ããªèŒžæ¶²å®¹åšãææ¡ãããŠããã
ããã«ãè¬å€å®¹åšã§ãããã€ã¢ã«ïŒïŒïŒãå容ã
ãã«ãã»ã«ïŒïŒïŒãšãè¬æ¶²ååºå£ãæãã溶解液
ã®å ¥ã€ãå¯ææ§å®¹åšïŒïŒïŒãšããããŠãŒãïŒïŒïŒ
ã§æ¥ç¶ããããã®ã§ããããããŠããŠãŒãïŒïŒïŒ
å ã«ã¯ããã€ã¢ã«ïŒïŒïŒåŽã«äžç©ºã®ç©¿åºéïŒïŒïŒ
ãåãã€ããããå¯ææ§å®¹åšïŒïŒïŒåŽã«ç Žæéšæ
ïŒïŒïŒãåãã€ããããŠãããåèšç ŽæéšæïŒïŒ
ïŒã¯ããŠãŒãïŒïŒïŒå ã®éè·¯ãéããŠããã液äœ
ã®æµéãé»æ¢ããŠãããã«ãã»ã«ïŒïŒïŒã®äžéšã«
ã¯å¯ææ§éšæãããªããã€ããïŒïŒïŒãã·ãŒã«æ§
ãä¿ã¡ã€ã€åãä»ããããŠããã該å¯ææ§éšæã¯
人æã«ããäžééåãå¯èœãšããããã«å®è³ªäžå€
圢èªåšã§ããã
ã®ãã€ããïŒïŒïŒã®å¹³å£ãªäžå€®éšæïŒïŒïŒãæã§
æŒããŠãã€ã¢ã«ïŒïŒïŒãæŒãäžããç©¿åºéïŒïŒïŒ
ã§ãã€ã¢ã«ïŒïŒïŒã®ãŽã æ ïŒïŒïŒã貫ãå¯ææ§å®¹
åšïŒïŒïŒãšãã€ã¢ã«ïŒïŒïŒãšããŸãé£çµããïŒå³
ïŒïŒåç §ïŒãã€ãã§ãããŠãŒãïŒïŒïŒå ã®ç Žæéš
æïŒïŒïŒãæã§æãæ²ããããã«ããããŠãŒãïŒ
ïŒïŒå ã®éè·¯ãééãããè¬å€ãšæº¶è§£æ¶²ãšãæ··å
ããããã«ãªã€ãŠããã
ãã®å 容ç©ãæ··åããæ¹æ³ãšããŠãå³ïŒïŒãïŒïŒ
ã«ç€ºãããæ段ãå¿çšããããšãèããããïŒå®
éæ63â46148å·å ¬å ±åç §ïŒã
ãŠãã容åšæ¬äœïŒïŒïŒã®éŠéšïŒïŒïŒã«å³ïŒïŒã«ç€º
ããããããªæºã圢æãããŠããã䜿çšåã«ãã€
ãŠã¯ãèïŒïŒïŒã®åžéšïŒïŒïŒã¯æºïŒïŒïŒãšåµåã
ããããŠããïŒå³ïŒïŒåç §ïŒããããŠã䜿çšã«é
ããŠã¯ãèïŒïŒïŒã®åžéšïŒïŒïŒãåèšæºïŒïŒïŒã
ããã€ããã¯ãããã€ãã§åããéŠéšïŒïŒïŒã«åœ¢
æãããå¥ã®ãããç¶ã®æºïŒïŒïŒã«åµããèïŒïŒ
ïŒãå転ããããšã«ããåœè©²èïŒïŒïŒã容åšæ¬äœ
ïŒïŒïŒã®æ¹åãžãšç§»åãããã®ã§ãããããã«ã
ããéè§ã«åœ¢æãããè¬æ¶²æµåºçïŒïŒïŒã®äžç«¯éš
ïŒïŒïŒã容åšæ¬äœïŒïŒïŒã®å£éšã«æº¶çãããèè
ïŒïŒïŒãçªãç Žã€ãŠå€éšãšã®é£éç¶æ ãããã
ãããšãããŠããïŒå³ïŒïŒåç §ïŒã
ããå³ïŒïŒãïŒïŒã«ç€ºãããåŸæ¥æè¡ã§ã¯ããã€
ããïŒïŒïŒãäžæ¹ãžç§»åãããŠãã€ã¢ã«ïŒïŒïŒã
æŒãäžããããã«ããŠãããããé£éæäœæã«ã«
ãã»ã«ïŒïŒïŒã®å å§ãäžæããé£éæäœãã¹ã ãŒ
ãºã«è¡ãªãããšãã§ããªãã°ãããããããŸãã
ãã€ããïŒïŒïŒãæã§äžæ¹ãžæŒãéã«çªãã€ãã
ïŒïŒïŒãå·ã€ããåœè©²ãã€ããïŒïŒïŒãç ŽããŠç¡
èæ§ãç Žæãããæ§ããããã
è¡ã§ã¯ãè¬æ¶²å®¹åšã®äœ¿çšæãããªãã¡å®¹åšå éšã®
è¬æ¶²ãšå€éšãšãé£éç¶æ ã«ãããšãã«ããã€ãã
èãã¯ãããŠãå床å¥ã®æºã«åµããªããã°ãªã
ããè¬èïŒïŒïŒãè¬æ¶²æµåºçïŒïŒïŒã®éå©éšåãª
ã©ã倧æ°äžã®çŽ°èã«æ±æãããŠããŸãããã®çŽ°è
ãè¬æ¶²äžã«æ··å ¥ããŠããŸãæ§ããããããŸããè
èªèº«ãäžæ¹ãžç§»åããããé£éæäœæã«å®¹åšã®å
å§ãäžæããé£éæäœãã¹ã ãŒãºã«è¡ãªãããšã
ã§ããªãã°ãããããã
ã«ãã€ããã¯ããããšãªããç¡èæ§ãä¿ã¡ã€ã€é£
éæäœãè¡ãããšãã§ãããšãšãã«ã¹ã ãŒãºã«é£
éæäœãè¡ãªãããšãã§ãã茞液容åšãæäŸãã
ããšãç®çããã
åšã¯ã (a) å éšã«æº¶è§£æ¶²ãŸãã¯åžé液ãåçŽãããäžç«¯
ã«ééèã§ééããã液äœéè·¯éšãæããå¯ææ§
容åšãšã (b) 該å¯ææ§å®¹åšã«é£çµãããŠããããã®å é¢ã«
ã¬ã€ãã圢æãããã«ãã»ã«ãšã (c) å£éšãåºéå¯èœãªæ ã§å¯å°ãããŠãããåèš
ã«ãã»ã«å ã«ä¿æãããè¬å€å®¹åšãšã (d) åèšå¯ææ§å®¹åšã®å éšãšè¬å€å®¹åšã®å éšãšã
é£éããé£éæ段ãšã (e) åèšã«ãã»ã«ã«æ°å¯ã«è¢«å ããããåèšè¬å€
容åšãäžéãããããã®ãã€ãããšã (f) åèšã«ãã»ã«ã®ã¬ã€ãã®æºã«åµãŸãã¬ã€ãæ£
ãåããŠããããã€è¬å€å®¹åšã®åºéšã«åµãããã
æŒãéšæ ãšãããªããåèšãã€ããã®é éšäžé¢ã«å匧ç¶ã®
æ¿ãããªãäžå¯Ÿã®ã«ã ã軞察称ã«åœ¢æãããŠã
ããåèšæŒãéšæãšã«ã ãšãä¿åããŠããããã€
ããã®å転ã«ããåèšã«ã ãæŒãéšæãä»ããŠè¬
å€å®¹åšãäžæ¹ãžç§»åãããåèšé£éæ段ã«ãã€ãŠ
è¬å€å®¹åšã®å éšãšå¯ææ§å®¹åšã®å éšãšãé£éãã
ãããã«æ§æãããããšãç¹åŸŽãšããŠããã
é¢ã«åœ¢æãããã«ã ãšãè¬å€å®¹åšã®åºéšã«åµãã
ããæŒãéšæãšãçšããŠããã€ããã®å転éåã
æŒãéšæã®äžééåãžãšè»¢æãããŠãããããã
ãã®è»¢æããã€ããã被å ãããŸãŸã§è¡ãããšã
ã§ããã®ã§çŽ°èã®äŸµå ¥ãå®å šã«é²æ¢ããããšãã§
ããããŸãããã€ããèªèº«ã¯å転éåãè¡ãã ã
ã§äžæ¹ã«ç§»åããããšããªãã®ã§é£éæäœæã«å®¹
åšã®å å§ãäžæããããšã¯ãªãã
液容åšã説æããã
液容åšã®èŠéšæé¢å³ãå³ïŒã¯ã«ãã»ã«ã®çžŠæé¢
å³ãå³ïŒã¯ã«ãã»ã«ã®å¹³é¢å³ãå³ïŒã¯ã«ãã»ã«ã®
ä¿åçªèµ·ã®æ¡å€§å³ãå³ïŒã¯ã«ãã»ã«ã®çµåéšã®æ¡
倧æé¢å³ãå³ïŒã¯æŒäžãæ©æ§ã®äžéšç ŽææèŠå³ã
å³ïŒã¯å¶åæ段ã®æ£é¢å³ãå³ïŒã¯å¶åæ段ã®å¹³é¢
å³ãå³ïŒã¯åºéé åºå¶åŸ¡æ©æ§ã®äžéšç ŽææèŠå³ã
å³ïŒïŒã¯æ¶²äœéè·¯éšã®çžŠæé¢å³ãå³ïŒïŒã¯ã©ããŒ
ã¹ãããã®çžŠæé¢å³ãå³ïŒïŒãïŒïŒã¯åèšå®æœäŸ
ã®åºéåäœé åºã瀺ãæé¢å³ãå³ïŒïŒãïŒïŒã¯æž
æ¶æ段ã®äžäŸã瀺ãæèŠå³ãå³ïŒïŒã¯æ¬çºæã®ä»
ã®å®æœäŸã«ãããã茞液容åšã®ãã€ããã瀺ãäž
éšç ŽææèŠå³ãå³ïŒïŒã¯åèšãã€ãããã«ãã»ã«
ã«è£ çããç¶æ ã®æ°Žå¹³æé¢å³ãå³ïŒïŒã¯åèšä»ã®
å®æœäŸã«ãããã茞液容åšã®ã«ãã»ã«ã®çžŠæé¢
å³ãå³ïŒïŒã¯åèšä»ã®å®æœäŸã«ããã茞液容åšã®
ã«ãã»ã«ãšããã°ã®çµåæ§é ã瀺ãæèŠå³ãå³ïŒ
ïŒã¯åèšä»ã®å®æœäŸã«ãããããã°ã®è¬æ¶²ååºå£
ã瀺ãäžéšæé¢å³ãå³ïŒïŒã¯æ¬çºæã«ãããŠçšã
ãããç©¿åºéã®ä»ã®äŸã瀺ãäžéšæé¢å³ã§ããã
æã説æããã
äžãããã°ãšããïŒãïŒã¯ã«ãã»ã«ãïŒã¯è¬å€å®¹
åšãšããŠã®è¬å€ãã€ã¢ã«ïŒä»¥äžåã«ããã€ã¢ã«ãš
ããïŒãïŒãã€ããã§ããã
質ã®å¡©åããã«æš¹èãããªãªã¬ãã€ã³ç³»æš¹èããš
ãã¬ã³é ¢é žããã«å ±éåäœãªã©ã®å¯ææ§ã«å¯ãæ
æã§åœ¢æããã容åšã§ããããªãããªãªã¬ãã€ã³
系暹èã¯èè¬åæ§ã«åªãã溶解液äžãžã®æº¶åºç©ã
å°ãªãã®ã§å¥œãŸãããããã°ïŒã®äžç«¯ã«ã¯æ¶²äœé
è·¯éšïŒïŒã圢æãããŠããããŸãäžç«¯ã«ã¯è¬æ¶²å
åºå£ïŒïŒã圢æãããŠããã
ãã®ç¥åçç¶ã®å®¹åšã§ãããããªãªã¬ãã€ã³ç³»æš¹
èãªã©ã®ææã§åœ¢æãããŠãããã«ãã»ã«ïŒã®äž
端ã¯éæŸãããŠãããäžç«¯ã«ã¯åºéšïŒïŒã圢æã
ããŠããããŸãåºéšïŒïŒã®äžé¢ã«ã¯æ¶²äœéè·¯éšïŒ
ïŒãçµåããããã®çµåéšïŒïŒã圢æãããŠã
ãããã®çµåéšïŒïŒã«åèšæ¶²äœéè·¯éšïŒïŒãæ¿å ¥
ããããšã«ããã«ãã»ã«ïŒãšããã°ïŒãšãé£çµã
ããã
çŽãããŠããããã®ãã€ã¢ã«ïŒã¯å ¬ç¥ã®ã¬ã©ã¹è£œ
ãŸãã¯ãã©ã¹ããã¯è£œã®ãã€ã¢ã«ã§ãããå éšã«
ã¯åºäœç¶ã®è¬å€ãå ¥ããããŠããããã€ã¢ã«ïŒã¯
ãã®å£éšïŒïŒãäžåãã«ãªãããã«åçŽãããå£
éšïŒïŒã¯åºéå¯èœãªãŽã æ ã§å¯å°ãããŠãããã«
ãã»ã«ïŒå éšã«ãããŠããã€ã¢ã«ïŒã®å£éšïŒïŒãš
ã«ãã»ã«åºéšïŒïŒãšã®éã«ã¯ç©¿åºéïŒãåºçãã
ãå¶åæ段ïŒãé 眮ãããŠããããã®å¶åæ段ïŒ
ã¯ç©¿åºéïŒã®åºéé åºãå¶åŸ¡ãããã®ã§ããã詳
现ã¯åŸè¿°ããã
å¯ã«è¢«å ãããŠããããã€ããïŒã¯ãã€ã¢ã«ïŒã
ç¡èçã«ä¿è·ãããšãšãã«ããã€ã¢ã«ïŒãæŒãäž
ããåããå¥ãããã®ã§ããããã€ããïŒã®äžé¢
ã«ã¯æžæ¶æ段ïŒïŒãèšããããŠããããã®æžæ¶æ
段ïŒïŒã¯èŒžæ¶²å®¹åšãåãäžããããã®ãã®ã§ãã
ãšãã°ç¬¬ïŒïŒãïŒïŒå³ã«ç€ºããããããªãããã¯
ã«åŒã€æããããã®æžåç°ïŒïŒïœãšæžå垯ïŒïŒïœ
ãšãããªããæžåç°ïŒïŒïœã¯ãã³ãžéšïŒïŒïœã§æ
ãæ²ãããããã«ãããã®ãçšããããã
现ã«èª¬æããã
ããŠãããç¥åçç¶ã®ã«ãã»ã«ïŒã¯è»žæ¹åã«æ²¿ã€
ãŠäžæ¹ããé ã«ãäžç«¯éšïŒïŒãäžééšïŒïŒãäžç«¯
éšïŒïŒãæããŠãããäžç«¯éšïŒïŒã¯åèšãã€ãã
ïŒã被å ãããéšåã§ãããäžç«¯éšïŒïŒã®äžç«¯å€
åšã«ã¯ä¿åçªèµ·ïŒïŒãç°ç¶ã«åœ¢æãããŠããïŒå³
ïŒåç §ïŒãã«ãã»ã«ïŒã®å å£é¢ã«ãããŠã¯ãäžç«¯
éšïŒïŒããäžç«¯éšïŒïŒã«ãããŠã¬ã€ãïŒïŒã圢æ
ãããŠããããã®ã¬ã€ãïŒïŒã¯ïŒæ¬ã®å¹ åºã®çžŠãª
ãïŒïŒïœïŒïŒïŒïœã«ãã€ãŠãæºåæºïŒïŒïœã圢æ
ãããã®ã§ãã«ãã»ã«äžå¿è»žã«å¯Ÿã軞察称ã«ïŒã«
æ圢æãããŠããããã®ã¬ã€ãïŒïŒã¯ãåŸè¿°ãã
æŒãéšæãå転äžèœã«ææãã軞æ¹åãžã®ç§»åã®
ã¿ãæ¡å ãããã®ã§ããã
眮ã«ãããŠãã«ãã»ã«ïŒã®å å£é¢ã«ã¯äžééšïŒïŒ
ã®éšåã«ãã¬ã€ãïŒïŒã圢æãããŠããããã®ã¬
ã€ãïŒïŒã¯ïŒæ¬ã®çžŠãªãïŒïŒïœïŒïŒïŒïœã«ãã€ãŠ
æºïŒïŒïœã圢æãããã®ã§ããããã«ãã»ã«äžå¿
軞ã«å¯Ÿã軞察称ã«ïŒã«æ圢æãããŠããããŸãã¬
ã€ãïŒïŒã®æäžæ®µã«ã¯ææ¢éšïŒïŒã圢æãããŠã
ããã¬ã€ãïŒïŒã¯åèšå¶åæ段ïŒãååäžèœã«æ
æããææ¢éšïŒïŒã¯å¶åæ段ïŒã®åºéé åºãå¶åŸ¡
ããããã«èšããããŠããã
ïŒã瞊æ¹åïŒå³ïŒã«ãããäžäžæ¹åã®ããšãã
ãïŒã«åœ¢æãããŠããããã®ãªãïŒïŒã¯ã«ãã»ã«
ïŒå ã§ãã€ã¢ã«ïŒãåçŽã«ä¿æãããã€å€åãå
ãããšãã¯è»žæ¹å移åèªåšã«ä¿æãããã®ã§ã
ãã
åãããŠããããã®åïŒïŒã¯ç©¿åºéïŒãéããšãš
ãã«ãåŸè¿°ããã©ããŒã¹ãããïŒïŒãæ¿å ¥ããå
ã§ããã
ãšå軞ã«åœ¢æãããŠããããã®çµåéšïŒïŒã¯å³ïŒ
ã«ç€ºããŠããããã«ãäºéçã§ãããããã ã®ç°
ç¶æºïŒïŒå ã«æ¶²äœéè·¯éšïŒïŒã®äžç«¯éšãæ¿å ¥ãã
ãããã«ãªã€ãŠããããããŠè©²æºïŒïŒã®å å£ã«ã¯
ä¿åæºïŒïŒã圢æãããŠããã
æŒãäžãæ©æ§ãå³ïŒã«åºã¥ã説æããã
ïŒãšãæããçç¶äœã§ããïŒãªãé éšïŒïŒäžé¢ã«
ã¯æžæ¶æ段ïŒïŒãèšããããŠãããå³ïŒã§ã¯å³ç€º
ãããŠããªãïŒãåŽå£ïŒïŒã®äžç«¯éšå åšé¢ã«ã¯ç°
ç¶ã®ä¿åæºïŒïŒã圢æãããŠããããã€ããïŒã
ã«ãã»ã«ïŒã®äžç«¯éšïŒïŒã«è¢«ãããšãä¿åæºïŒïŒ
ãã«ãã»ã«ïŒã®ä¿åçªèµ·ïŒïŒã«åµãŸãããã€ãã
ïŒã¯ã«ãã»ã«ïŒã«å¯Ÿãå転èªåšã§ããã軞æ¹å移
åäžèœã«åãã€ããããããã€ããïŒã®é éšïŒïŒ
äžé¢ã«ã¯ïŒæã®ã«ã ïŒïŒã圢æãããŠããããã®
ã«ã ïŒïŒã¯çŽ140ãã®è§åºŠã«ããã€ãŠåœ¢æãããå
匧ç¶ã®æ¿ã§è»žå¯Ÿç§°ã«äžå¯ŸèšããããŠããããããŠ
åã«ã ïŒïŒã®é«ãã¯äžçŽç·ç¶ã«å€åããŠãããäž
æ¹ãã«ãã»ã«ïŒã®å éšã«ã¯ãã€ã¢ã«ïŒãå ¥ããã
ãŠãããã«ãã»ã«ïŒã®äžç«¯éå£ã«ã¯ãã€ã¢ã«ïŒã®
åºéšïŒïœãäœçœ®ããŠããããããŠãã€ã¢ã«ïŒã®åº
éšïŒïœã«ã¯æŒãéšæïŒãåµããããŠããã
ãããã¬ã€ãæ£ïŒïŒãããªãã«ã¹ã¬ã€ç¶ã®éšæã§
ãããåã¬ã€ãæ£ïŒïŒã®äžç«¯ã«ã¯æé¢ã«åœ¢æãã
ãã«ã ããªãã¢éšïŒïŒã圢æãããŠãããã¬ã€ã
æ£ïŒïŒã¯ã«ãã»ã«ïŒã®å é¢ã«åœ¢æãããã¬ã€ãïŒ
ïŒã®æºïŒïŒïœã«åµãŸããå転äžèœãã€è»žæ¹å移å
èªåšã«ã¬ã€ãããæéããã
éšïŒïŒã«ãã€ããïŒãåµåããç¶æ ã§ããã€ãã
ïŒãå転ããããšãã«ã ïŒïŒãæŒãéšæïŒã®ã«ã
ããªãã¢éšïŒïŒã«åœæ¥ããŠæŒãéšæïŒãšãšãã«ã
ã€ã¢ã«ïŒãã«ãã»ã«ïŒå ã§äžæ¹ã«æŒãäžããããš
ãã§ããã
埡æ©æ§ã第ïŒãïŒå³ã«åºã¥ã説æããã
ããããã®å¶åæ段ïŒã¯è éšïŒïŒãšããã®äž¡ç«¯ã«
ç«èšãããä¿æ¢éšïŒïŒãšãä¿æ¢éšïŒïŒããå åŽã«
ç«èšãããæŒå§éšïŒïŒãšãæããããªãããã¬ã³
ãªã©ã®å¯ææ§ã®ããåææš¹èã«ããæ圢ãããŠã
ããä¿æ¢éšïŒïŒã®å 端ã«ã¯ä¿æ¢çªïŒïŒã暪æ¹åå€
åãã«çªåºããŠããããŸãæŒå§éšïŒïŒã®é éšã¯ã
ã€ã¢ã«ïŒã®éŠéšïŒïŒã«åµãŸã圢ç¶ãšãªã€ãŠããã
ïŒåã®æŒå§éšïŒïŒéã®ééã¯ãã€ã¢ã«ïŒã®å£éšïŒ
ïŒã®å€åŸããå°ãããéŠéšïŒïŒã®å€åŸããããã
倧ãã倧ããã§ããããŸãæŒå§éšïŒïŒãšä¿æ¢éšïŒ
ïŒãšã®éã«ã¯ä¿æ¢éšïŒïŒãå åŽã«æãã ãã®ãé
ãèšããããŠãããåèšè éšïŒïŒã®äžå€®äžéšã«ã¯
ç©¿åºéïŒã®ããïŒïŒãäžäœã«æ圢ãããŠãããã
ã®äžå¿ã®åïŒïŒã«ã¯ç©¿åºéïŒã®éäœãæ¿å ¥ããã
åºçãããŠããã
ãã«ã«ãã»ã«ïŒå éšã«å ¥ãããä¿æ¢çªïŒïŒãã«ã
ã»ã«ïŒã®ææ¢éšïŒïŒã«åœæ¥ããããã«è£ çãã
ãããã®å¶åæ段ïŒãšç©¿åºéïŒã«ããç¹èš±è«æ±ã®
ç¯å²ã«ããé£éæ段ãæ§æãããŠããããªããé£
éæ段ãšããŠã¯ãç¹è¡šæ61â501129å·å ¬å ±ã«ç€ºã
ããŠããç Žæéšæãããªãé£éæ段ãå«ãå ¬ç¥ã®
é£éæ段ãçšããããšãã§ããã
ããè¬å€ã®äžäŸãšããŠã¯ã€ãã®ãã®ãããã
ãªãŠã ãã»ãããŸãã·ã ãããªãŠã ãå¡©é žã»ããª
ãã¢ã ãå¡©é žã»ãã¡ããã·ã ãã»ãã¢ã»ããªã«ã
ããªãŠã ãã»ãã¢ãã³ããŒã«ãããªãŠã ãã»ãã¢
ããªãžã³ãã»ãã¢ã¿ãã·ã ãããªãŠã ãã»ããªã
ã¿ã³ãããªãŠã ãã»ããªãã©ãŸã³ãããªãŠã ãã»
ãã¹ããžã³ãããªãŠã ãã»ãããŸãŒã«ãããªãŠ
ã ãã»ããã©ãããããªãŠã ãã»ãã¡ã¿ãŸãŒã«ã
ããªãŠã ãã»ãããã·ã ãããªãŠã ãªã©ã®ã»ããš
ã ç³»æçç©è³ªããŸãã¢ã³ãã·ãªã³ãããªãŠã ãã«
ã«ããã·ãªã³ãããªãŠã ãã¹ã«ããã·ãªã³ãããª
ãŠã ããã«ã«ã·ãªã³ãããªãŠã ãªã©ã®ããã·ãªã³
ç³»æçç©è³ªããããæè «çå€ãšããŠã¯ããã€ãã
ã€ã·ã³ïŒ£ããã«ãªããŠã©ã·ã«ããã¬ããŒã«ãã·ã¿
ã©ãã³ãªã©ããããæ朰çå€ãšããŠã¯ããã¢ã¢ã
ãžã³ãå¡©é žã©ãããžã³ãã·ã¡ããžã³ãªã©ãããã
ã¯ãããšãã°ççé£å¡©æ°ŽãïŒïŒ ãããŠç³æ¶²ã泚å°
çšèžæºæ°Žã®ã»ããåçš®ã®é»è§£è³ªãå«ã溶液ãçšã
ãããã
ã®ãããšãã°ããªãªã¬ãã€ã³ç³»æš¹èãªã©ã§æ圢ã
ããçç¶äœã§ãããå³ïŒïŒã«ç€ºãããŠããããã«
äžç«¯éšïŒïŒãšäžç«¯éšïŒïŒãšãæããŠãããäžç«¯éš
ïŒïŒã®å€åšã«ã¯ä¿åçªèµ·ïŒïŒãšãã©ã³ãžïŒïŒãšã
圢æãããŠãããä¿åçªèµ·ïŒïŒã¯åèšçµåéšïŒïŒ
ã®ä¿åæºïŒïŒã«åµãŸã該液äœéè·¯éšïŒïŒãçµåéš
ïŒïŒããæããªãããã«ãã€ãããšçµåãããäž
端éšïŒïŒã¯ããã°ïŒã®æ¬äœã«ã€ã³ãã«ã¹ã·ãŒã©ã
å ç±éåãé«åšæ³¢ãŠãšã«ããŒãè¶ é³æ³¢çºçè£ çœ®ãª
ã©ã®æ段ã§æº¶çãããŠããã
éèïŒïŒãäžäœåœ¢æãããŠããããã®ééèïŒïŒ
ã¯å šäœãŸãã¯äžéšã®èåãèãèã§ãç©¿åºéïŒã§
åºéããããŸã§ã¯ãããã°ïŒå ã液å¯ã«ä¿ã€åã
ãå¥ããã
ããŠãããã©ããŒã¹ãããïŒïŒã¯æº¶è§£æ¶²ãã«ãã»
ã«ïŒå ã«ãªãŒã¯ããã®ãé²ãããã®åºéšïŒïŒãå
ãããŽã 補ã®çç¶äœã§ãããçäœïŒïŒã®äžç«¯éšå
åšé¢ã«ã¯ç°ç¶ãªãïŒïŒã圢æãããŠããããã®ãª
ãïŒïŒã¯ç©¿åºéïŒã®åŸè¿°ããããå€åšã«å¯çãã
ãã®ã§ãããåèšåºéšïŒïŒã®å åšé¢äžå€®ã«ã¯åé
圢ã®åãæ¬ ãïŒïŒã圢æãããç©¿åºéïŒãåºéã
ããšãã«åå ã«ãã€ãŠãŽã ãåãåãããããã
ç©¿åºéïŒå ã«è©°ãŸãäºæ ã®çºçãé²æ¢ããŠããã
ãã®ã©ããŒã¹ãããïŒïŒã¯åèšæ¶²äœéè·¯éšïŒïŒã®
ã«ãã»ã«ïŒåŽå åšã«åµãããããšãåèšåºéšïŒïŒ
ã¯æ¶²äœéè·¯éšïŒïŒäžã®ééèïŒïŒã®ã«ãã»ã«ïŒåŽ
è¡šé¢ã«æ¥è§Šããããã«ãªã€ãŠããã
ã茞液容åšã®é£éåäœãå³ïŒïŒãïŒïŒã«åºã¥ã説
æããã
ãããšãã«ã ïŒïŒãæŒãéšæïŒãæŒãäžããã®
ã§ããã€ã¢ã«ïŒã¯äžéãããããããã€ã¢ã«ïŒã®
å£éšïŒïŒãå¶åæ段ïŒã®æŒå§éšïŒïŒãå€æ¹ã«æŒã
æ²ãããšã該æŒå§éšïŒïŒãšä¿æ¢çªïŒïŒãšã®ééã
çããªãã®ã§ä¿æ¢çªïŒïŒãææ¢éšïŒïŒããæãåº
ãããšããŠãæŒå§éšïŒïŒã«åœã€ãŠãæãåºããªã
ãªããã€ã¢ã«ïŒãäžéããã«ãããããããå¶å
æ段ïŒã¯äžéããããšããªãã
ããããšããã€ã¢ã«ïŒãäžéããŠããã®å£éšïŒïŒ
ãå¶åæ段ïŒã®ïŒåã®æŒå§éšïŒïŒã®éã«ã¯ããŸã
ãããã®ãšãå£éšïŒïŒå ã®ãŽã æ ïŒïŒãç©¿åºéïŒ
ã®äžåŽã®åã«ããåºéãããã
ã®ããã«æŒå§éšïŒïŒãšä¿æ¢çªïŒïŒãšã®ãéãçã
ã®ã§ãå¶åæ段ïŒã¯äžéããªãããåºéã®å®äºãš
åæã«æŒå§éšïŒïŒãã»ãŒçŽç«ããç¶æ ã«åŸ©åž°ãä¿
æ¢çªïŒïŒãšã®éã®ãéã倧ãããªãïŒå³ïŒïŒå
ç §ïŒãããã«ããå¶åæ段ïŒãææ¢éšïŒïŒããè±
åºããŠäžéãããç¶æ ãšãªãã
ãšããã€ã¢ã«ïŒãäžéããããä¿æ¢éšïŒïŒãå åŽ
ã«æããããã®ã§ãå¶åæ段ïŒãäžç·ã«äžéãã
ïŒå³ïŒïŒåç §ïŒãããããŠãç©¿åºéïŒã®äžåŽã®åã«
ããã©ããŒã¹ãããïŒïŒã®åºéšïŒïŒãšæ¶²äœéè·¯éš
ïŒïŒã®ééèïŒïŒãšãé£ç¶çã«åºéãããããã
ã«ããããã€ã¢ã«ïŒã®å éšãšããã°ïŒã®å éšãšã
ç©¿åºéïŒã«ããé£éãããããã®ããã«ãå ã«ã«
ãã»ã«ïŒå ã®ãã€ã¢ã«ïŒã®ãŽã æ ïŒïŒãåºéãã
ã€ãã§ããã°ïŒã®ééèïŒïŒãåºéããããã«ã
ãŠããã®ã§ãããã°ïŒå ã®æº¶è§£æ¶²ãã«ãã»ã«ïŒå
ã«æŽ©ããããšããªãããªãããïŒïŒã®åšå²ã«ã¯ã©
ããŒã¹ãããïŒïŒã®ç°ç¶ãªãïŒïŒãæåããå¯ç
ããŠãããç©¿åºéïŒã«ããééèïŒïŒã®åºéã®å
æ段éã§ã溶解液ã®æŽ©ããé²æ¢ããŠããã
ïŒãšãé£éãããšãããã°ïŒãå§è¿«ãããããã
ã ãããŠå éšã®æº¶è§£æ¶²ã®äžéšããã€ã¢ã«ïŒå ã«é
ã蟌ãã§ããã€ã¢ã«ïŒå ã®è¬å€ã溶解ããããã
ãŠåã³ããã°ïŒãå§è¿«ããããããã ããããšã
ãã€ã¢ã«ïŒå ã®è¬æ¶²ã¯ãããã°ïŒå ã«æ»ããæ»ã
ããè¬æ¶²ã¯ããã°ïŒã®è¬æ¶²ååºå£ïŒïŒã«èŒžæ¶²ããŠ
ãŒããªã©ãæ¥ç¶ããŠèŒžæ¶²ãšããŠçšããããã
ïŒïŒã«åºã¥ã説æããããªãã以äžã®èª¬æ以å€ã®
äºé ã¯åèšå®æœäŸãšå®è³ªçã«å€ããšããã¯ãªãã
ããäžéšç Žæå³ã§ããããã€ããïŒã®åŽå£ïŒïŒãš
ã«ã ïŒïŒãšã®éã«ã¯é éšïŒïŒã«å¯çããããã«ãª
ã³ã°ç¶ã®ãŽã ãããã³ïŒïŒãå ¥ããããŠãããã
ã®ããã«ããŽã ãããã³ïŒïŒãå ¥ãããšãã¯ã«ã
ã»ã«ïŒã®äžç«¯é¢ãšãã€ããïŒã®å å£é¢ãšãå¯éã
ããã®ã§ãæ°å¯æ§ãé«ããªããšããå©ç¹ãããã
ïŒã®äžå€®ã«åµååïŒïŒã圢æããããã®ãçšãã
ããŠãããäžæ¹ãã€ããïŒã®é éšïŒïŒã®å å£é¢äž
倮ã«ã¯çªèµ·ïŒïŒã圢æãããŠãããæŒãéšæïŒã¯
åµååïŒïŒãçªèµ·ïŒïŒã«åµåããããšã«ãããç°¡
åã«ã¯è±èœããªãããã«ä¿æãããããããã€ãŠ
æ¬çºæã®èŒžæ¶²å®¹åšãçµã¿ç«ãŠãéãæŒãéšæïŒã
å³ç€ºã®ããšãåµåãããŠããã°ãåæã«è±èœããª
ãã®ã§ãçµç«äœæ¥ã容æãšãªãããªããçµç«å®äº
åŸã«äœ¿çšããéããã€ããïŒãåãããŠã«ã ïŒïŒ
ã§æŒãéšæïŒãæŒãäžããã°ãåµååïŒïŒãšçªèµ·
ïŒïŒãšã®åµåã¯ç°¡åã«å€ããããšã¯ãã¡ããã§ã
ãã
ã«ã ïŒïŒã¯ããšã³ãéšåã«ã¹ãããïŒïŒã圢æã
ããŠããããã®ã¹ãããïŒïŒã¯ããªãïŒïŒãšãªã
ïŒïŒãšãã®éã®æºïŒïŒïœãããªãããªãïŒïŒã¯æ
é¢ã«åœ¢æãããŠãããäžæ¹ãã«ãã»ã«ïŒã¯å³ïŒïŒ
ãïŒïŒã«ç€ºãããããã«ããã®å åšã«åœ¢æããã
ãªãïŒïŒã®äžæ¹ãäžç«¯éšïŒïŒãŸã§å»¶ã³ããªã延é·
éšïŒïŒïœãæããŠããã
ããå³ïŒïŒã«ç€ºãããã«ãã€ããïŒãåãŸããã
ãšãã¯ãã¡ããã©ãã€ã¢ã«ïŒãæŒãäžããã€ããš
ãã«ãã¹ãããïŒïŒããªã延é·éšïŒïŒïœã«åµãå
ãããã«ãªã€ãŠããããªããªãïŒïŒã¯æé¢ã«åœ¢æ
ãããŠããã®ã§ããªã延é·éšïŒïŒïœãä¹ãè¶ãã
ãšãã¯æµæã¯å°ãããªã€ãŠãããããããã€ãã
æºïŒïŒïœã®äžã«ãªã延é·éšïŒïŒïœãå ¥ã€ããã¯ã
äž¡ãµã€ãã®ãªãïŒïŒïŒïŒïŒããªã延é·éšïŒïŒïœã«
åœãã®ã§ããã€ããïŒã®å転ã¯é»æ¢ãããã
ãåããŠããã®ã§ããŽã æ ïŒïŒãç©¿åºéïŒã«è²«ã
ãããšãã®åŒŸçºåã«ãã€ãŠããã€ã¢ã«ïŒãäžæ¹ã«
æŒãäžããããããšããŠãããããé»æ¢ããããš
ãã§ããããããã€ãŠãç©¿åºéïŒã«ãããŽã æ ïŒ
ïŒã®åºéãå®å šã«ããããšãã§ããã
ãããŠã¯ãã«ãã»ã«ïŒå ã®ææ¢éšïŒïŒã®äžæ¹äœ
眮ãããªãã¡ã¬ã€ãïŒïŒã®äžæ¹äœçœ®ã«çªèµ·ïŒïŒã
圢æãããŠããããã®çªèµ·ïŒïŒã¯ãå¶åæ段ïŒã
ãã®ä¿æ¢çªïŒïŒãææ¢éšïŒïŒäžã«äœçœ®ãããã
ã«ãã«ãã»ã«ïŒã«å ¥ãããšããåèšä¿æ¢çªïŒïŒã®
äžæ¹ã«äœçœ®ãããããšåœæ¥ãããããã«ãªã€ãŠã
ãããããã€ãŠããã®çªèµ·ïŒïŒã¯èŒžæ¶²å®¹åšã®çµã¿
ç«ãŠäžã«ãå¶åæ段ïŒã®åæãªåããé»æ¢ããã
ããšãããçµã¿ç«ãŠäœæ¥ã容æã«ããå©ç¹ãæã
ãã
ã«ïŒãšããã°ïŒã®çµåæ§é ã瀺ãããŠãããã«ã
ã»ã«ïŒã®çµåéšïŒïŒã«ã¯çµååïŒïŒãç©¿åããã
ãŸãããã°ïŒã®æ¶²äœéè·¯éšïŒïŒã«ã¯ä¿åçªèµ·ïŒïŒ
ãèšããããŠããããããã¯äºãã«åµåããŠçµå
ãããããã«ãªã€ãŠããã第ïŒïŒå³ã«ã¯ãã®çµå
ç¶æ ã瀺ãããŠããã
ïŒã«ããçµåã¯çµå匷床ãé«ããçµååŸã¯å®¹æã«
å€ããªããšããå©ç¹ãããã
ã¯ãå³ïŒïŒã«ç€ºãããŠããããã«çµåéšïŒïŒã®å
åšå£ïŒïŒã®å éšã«æ¿å ¥ãããŠããããã®ã©ããŒã¹
ãããïŒïŒã¯ãã®åºéšïŒïŒãå šäœã«èèã«ããã
ãã®ã§ãåèšå®æœäŸã®å³ïŒïŒã«ç€ºãããã©ããŒã¹
ãããïŒïŒã®ãããªåãæ¬ ãã¯åœ¢æãããŠããª
ããããããåºéšïŒïŒå šäœãèèã«ãããŠããã
ãšã§ãç©¿åºéïŒã®åºéæµæã¯å³ïŒïŒã®ã©ããŒã¹ã
ããïŒïŒãšåæ§ã«äœæžãããŠããã
ã«ç€ºãããŠãããåå³ã«ç€ºãããŠããããã«ãè¬
液ååºå£ïŒïŒã®åºç«¯ã«ã¯ãã©ã³ãžïŒïŒã圢æã
ãã該ãã©ã³ãžïŒïŒã«ã¯æ ãã€ããïŒïŒãæ¥åã
ããŠããããã®æ ãã€ããïŒïŒå ã«ã¯ãŽã æ ïŒïŒ
ãæ¿å ¥ãããŠããã該ãŽã æ ïŒïŒã®åºé¢ã«ã¯ã·ãŒ
ã«ïŒïŒã貌çãããŠãããã·ãŒã«ïŒïŒã®ææãšã
ãŠã¯ãã©ã¹ããã¯ã·ãŒããªã©ãçšãããããã®ã·
ãŒã«ïŒïŒã¯èŒžæ¶²å®¹åšã䜿çšããçŽåãŸã§è²ŒçããŠ
ããã䜿çšéå§æã«å¥ããã°ããããã®ãããªã·
ãŒã«ïŒïŒãçšããããšã«ããããŽã æ ïŒïŒã®è¡šé¢
ã®æ±æãé²æ¢ããããšãã§ããã
ãïŒïŒã«ç€ºããå®æœäŸãšåæ§ã«ããã€ãããåã
ã¯ããããšãªãè£ çãããŸãŸã§å転ãããã ãã§
è¬å€ãšæº¶è§£æ¶²ãšã®æ··åãç¡èçã«è¡ãããšãã§ã
ãã
ããããïŒæ¬ã®æµäœéè·¯ããã€ãã®ã§ãã€ããã
æ¬çºæã«ãããŠã¯ïŒæ¬ã®æµäœéè·¯ããã€ç©¿åºéïŒ
ïŒãçšããããšãã§ããããã®ãããªç©¿åºéïŒïŒ
ã¯ãããšãã°å³ïŒïŒã«ç€ºãããŠããããã«ïŒæ¬ã®
æµäœéè·¯ïŒïŒïœïŒïŒïŒïœã圢æããããã®ã§ã
ãããã®ç©¿åºéïŒïŒã«ãããŠã¯ãäžæ¹ã®éè·¯ã空
æ°ãéããä»æ¹ã®éè·¯ã液äœãéãã®ã§ã液äœã®
ééãæ©ããšããå©ç¹ãããããããã€ãŠãè¬å€
ãšæº¶è§£æ¶²ã®æ··åãããçæéã§è¡ããããšããäœ
çšãå¥ããã
çºæã¯ãã®èŠæšãéžè±ããªãç¯å²ã§çš®ã ã®å€æŽäŸ
ãæ¡çšããããšãã§ããã
茞液容åšã«ããã°ããã€ãããã«ãã»ã«ã«è¢«å ã
ããŸãŸã§åœè©²ãã€ãããå転ãããã ãã®æäœã§
è¬å€ãšæº¶è§£æ¶²ãšã®æ··åãè¡ãããšãã§ããã®ã§ã
茞液äžã«çŽ°èãäŸµå ¥ããã®ã確å®ã«é²æ¢ããããš
ãã§ããããŸãããã€ããèªèº«ã¯å転éåãè¡ã
ã ãã§äžæ¹ã«ç§»åããããšããªãã®ã§é£éæäœæ
ã«å®¹åšã®å å§ãäžæããããšã¯ãªããã¹ã ãŒãºã«
é£éæäœãè¡ãªãããšãã§ããã
èŠéšæé¢å³ã§ããã
ãã
ã§ããã
ã§ããã
ã§ããã
ã®ãã€ããã瀺ãäžéšç ŽææèŠå³ã§ããã
ã®æ°Žå¹³æé¢å³ã§ããã
ãã»ã«ã®çžŠæé¢å³ã§ããã
ã»ã«ãšããã°ã®çµåæ§é ã瀺ãæèŠå³ã§ããã
åºå£ã瀺ãäžéšæé¢å³ã§ããã
äŸã瀺ãäžéšæé¢å³ã§ããã
ãã
ãã
ãã
Claims (2)
- ãè«æ±é ïŒã (a) å éšã«æº¶è§£æ¶²ãŸãã¯åžé液ã
åçŽãããäžç«¯ã«ééèã§ééããã液äœéè·¯éš
ãæããå¯ææ§å®¹åšãšã (b) 該å¯ææ§å®¹åšã«é£çµãããŠããããã®å é¢ã«
ã¬ã€ãã圢æãããã«ãã»ã«ãšã (c) å£éšãåºéå¯èœãªæ ã§å¯å°ãããŠãããåèš
ã«ãã»ã«å ã«ä¿æãããè¬å€å®¹åšãšã (d) åèšå¯ææ§å®¹åšã®å éšãšè¬å€å®¹åšã®å éšãšã
é£éããé£éæ段ãšã (e) åèšã«ãã»ã«ã«æ°å¯ã«è¢«å ããããåèšè¬å€
容åšãäžéãããããã®ãã€ãããšã (f) åèšã«ãã»ã«ã®ã¬ã€ãã®æºã«åµãŸãã¬ã€ãæ£
ãåããŠããããã€è¬å€å®¹åšã®åºéšã«åµãããã
æŒãéšæ ãšãããªããåèšãã€ããã®é éšäžé¢ã«å匧ç¶ã®
æ¿ãããªãäžå¯Ÿã®ã«ã ã軞察称ã«åœ¢æãããŠã
ããåèšæŒãéšæãšã«ã ãšãä¿åããŠããããã€
ããã®å転ã«ããåèšã«ã ãæŒãéšæãä»ããŠè¬
å€å®¹åšãäžæ¹ãžç§»åãããåèšé£éæ段ã«ãã€ãŠ
è¬å€å®¹åšã®å éšãšå¯ææ§å®¹åšã®å éšãšãé£éãã
ãããã«æ§æãããããšãç¹åŸŽãšãã茞液容åšã - ãè«æ±é ïŒã åèšãã€ãããããã®é é¢ã«æžæ¶
æ段ãæãããã®ã§ããè«æ±é ïŒèšèŒã®èŒžæ¶²å®¹
åšã
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3150277A JPH04253863A (ja) | 1991-06-21 | 1991-06-21 | èŒžæ¶²å®¹åš |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3150277A JPH04253863A (ja) | 1991-06-21 | 1991-06-21 | èŒžæ¶²å®¹åš |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1064400A Division JPH021277A (ja) | 1988-03-31 | 1989-03-15 | èŒžæ¶²å®¹åš |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04253863A JPH04253863A (ja) | 1992-09-09 |
JPH0566141B2 true JPH0566141B2 (ja) | 1993-09-21 |
Family
ID=15493452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3150277A Granted JPH04253863A (ja) | 1991-06-21 | 1991-06-21 | èŒžæ¶²å®¹åš |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04253863A (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2555163Y2 (ja) * | 1993-03-25 | 1997-11-19 | æåé»å·¥æ ªåŒäŒç€Ÿ | èŒžæ¶²å®¹åš |
JPH08126683A (ja) * | 1994-10-31 | 1996-05-21 | Fujisawa Pharmaceut Co Ltd | 茞液çšå®¹åš |
DE69628284D1 (de) * | 1995-02-13 | 2003-06-26 | Fujisawa Pharmaceutical Co | TransfusionsbehÀlter |
ES2675729T3 (es) * | 2011-04-12 | 2018-07-12 | F. Hoffmann-La Roche Ag | Dispositivo de conexión |
-
1991
- 1991-06-21 JP JP3150277A patent/JPH04253863A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPH04253863A (ja) | 1992-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0572830B2 (ja) | ||
US5826713A (en) | Fluid vessel | |
US5308347A (en) | Transfusion device | |
EP1415636B1 (en) | Sliding reconstitution device for a diluent container | |
US6582415B1 (en) | Sliding reconstitution device for a diluent container | |
US5380315A (en) | Mixing apparatus | |
KR100569223B1 (ko) | ìŒì²Ží ìì¡ì©êž° | |
US7404814B2 (en) | Infusion vessel | |
CA2261428A1 (en) | Medicament container stopper with integral spike access means | |
US7115117B2 (en) | Infusion vessel | |
US5261902A (en) | Fluid container assembly | |
JP3565609B2 (ja) | æº¶è§£æ¶²æ³šå ¥ã»ãã | |
JPH0566141B2 (ja) | ||
JP3514505B2 (ja) | 溶解液容åšã®è£œé æ¹æ³ | |
JPH08238300A (ja) | 茞液çšå®¹åš | |
JPH0542833Y2 (ja) | ||
JPH07171192A (ja) | èŒžæ¶²å®¹åš | |
JPH07184979A (ja) | èŒžæ¶²å®¹åš | |
JP3238170B2 (ja) | èŒžæ¶²å®¹åš | |
JPH0591681U (ja) | èŒžæ¶²å®¹åš | |
JPH0638834B2 (ja) | èŒžæ¶²å®¹åš | |
JPH0542832Y2 (ja) | ||
JPH07313572A (ja) | èŒžæ¶²å®¹åš | |
JP4095851B2 (ja) | 茞液容åšåã³è¬å€åå®¹åš | |
JPH04327850A (ja) | èŒžæ¶²è£ çœ® |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080921 Year of fee payment: 15 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080921 Year of fee payment: 15 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090921 Year of fee payment: 16 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090921 Year of fee payment: 16 |